# Zhixin Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhixin-medical

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: www.innostic.com
- Total disclosed funding: $40M
- Latest round: Series A (Jan 29, 2018)
- Investors on record: 5

## About

Zhixin Medical, based in China, specializes in integrated medical services and products, focusing on healthcare supply chain solutions, including logistics and operational services for healthcare providers.Founded in 2010 and headquartered in Shanghai, China, Zhixin Medical operates in the healthcare sector, providing integrated medical services. The company has successfully completed three deals, with the latest being a Series A round that raised CNY 250.00 million led by ORIX Asia Capital. Their operations have remained consistent, focusing on enhancing logistical support for healthcare institutions. The founder, with a background in healthcare services, has previously established other companies, contributing to Zhixin Medical's strategic direction in the market.Zhixin Medical specializes in a range of integrated medical services and products, focusing primarily on the healthcare supply chain. Their core offerings include nationwide wholesale distribution, centralized supply services for hospitals, and third-party logistics services specifically catering to the in vitro diagnostics industry. The company also provides comprehensive operational services for consumer healthcare, as well as centralized management services for medical supplies within healthcare institutions. These services are designed to streamline procurement and distribution processes, ensuring efficiency and cost-effectiveness for healthcare providers. Their client base includes hospitals and medical institutions across various regions, with a focus on meeting the needs of urban healthcare facilities in China and potentially extending into broader Asian markets.Zhixin Medical's revenue structure is primarily driven by B2B transactions, selling services and products directly to healthcare institutions and distributors. In the most recent fiscal year 2024, the company reported a revenue of CNY 2,497,286,683.90, with an EBITDA of CNY 52,907,307. Transactions typically occur through established partnerships and contracts, particularly within the hospital supply chain, where clients engage the company for ongoing logistical and supply needs. By offering subscription-based services for medical supply management and leveraging agreements for centralized procurement, the company positions itself as a reliable partner in the healthcare sector. Their integrated services allow clients to maintain flexibility and reduce overhead costs associated with supply chain management.In September 2025, Zhixin Medical plans to raise CNY 445.51 million through an IPO on the Shenzhen Stock Exchange, selling 63.19 million shares at CNY 7.05 per share under the ticker "301584". This funding will support the development of new products and services aimed at expanding their market presence. The company is also targeting specific geographic expansion into broader Asian markets, leveraging its existing logistics capabilities to enhance supply chain efficiency for healthcare providers. The recent funding will facilitate these initiatives and support infrastructure improvements necessary for growth.

## Funding rounds

- Series A, Jan 29, 2018, $40M — Qiming Venture Partners, ORIX Asia Capital, Qiaojing Capital, June Lead Capital, Blossom Investment Management

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- ORIX Asia Capital — Series A
- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Series A
- June Lead Capital — Series A
- Blossom Investment Management (https://capitalatlas.ai/funds/blossom-investment-management) — Series A